{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:24:13Z","timestamp":1791267853102,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1002\/jps.22642","type":"journal-article","created":{"date-parts":[[2011,5,30]],"date-time":"2011-05-30T04:04:35Z","timestamp":1306728275000},"page":"3708-3718","source":"Crossref","is-referenced-by-count":42,"title":["Mother-to-fetus transfer of antiviral drugs and the involvement of transporters at the placental barrier"],"prefix":"10.1016","volume":"100","author":[{"given":"Masatoshi","family":"Tomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22642_bb0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1473-3099(07)70311-0","article-title":"Influenza vaccination in pregnancy: Current evidence and selected national policies","volume":"8","author":"Mak","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1002\/jps.22642_bb0015","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1086\/651484","article-title":"Prevention in neglected subpopulations: Prevention of mother-to-child transmission of HIV infection","volume":"50","author":"Mofenson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1002\/jps.22642_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2004.06.038","article-title":"Growth and function of the normal human placenta","volume":"114","author":"Gude","year":"2004","journal-title":"Thromb Res"},{"key":"10.1002\/jps.22642_bb0025","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.placenta.2005.09.001","article-title":"Designing pregnancy centered medications: Drugs which do not cross the human placenta","volume":"27","author":"Gedeon","year":"2006","journal-title":"Placenta"},{"key":"10.1002\/jps.22642_bb0030","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","article-title":"Drug transporters in the human blood\u2013placental barrier","volume":"158","author":"Vahakangas","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1002\/jps.22642_bb0035","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1248\/bpb.27.753","article-title":"Conditionally immortalized syncytiotrophoblast cell lines as new tools for study of the blood\u2013placenta barrier","volume":"27","author":"Kitano","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.22642_bb0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s004410050623","article-title":"Immunolocalization of GLUT1 and connexin 26 in the rat placenta","volume":"285","author":"Shin","year":"1996","journal-title":"Cell Tissue Res"},{"key":"10.1002\/jps.22642_bb0045","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1083\/jcb.140.6.1453","article-title":"Transplacental uptake of glucose is decreased in embryonic lethal connexin26-deficient mice","volume":"140","author":"Gabriel","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1002\/jps.22642_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0301-2115(00)00423-1","article-title":"Development of the placental villous tree and its consequences for fetal growth","volume":"92","author":"Kingdom","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1002\/jps.22642_bb0055","first-page":"76","article-title":"Fusion of cytothrophoblast with syncytiotrophoblast in the human placenta: Factors involved in syncytialization","volume":"5","author":"Gauster","year":"2008","journal-title":"J Reprod Med Endocrinol"},{"key":"10.1002\/jps.22642_bb0060","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.277.5332.1669","article-title":"Regulation of human placental development by oxygen tension","volume":"277","author":"Genbacev","year":"1997","journal-title":"Science"},{"key":"10.1002\/jps.22642_bb0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000146886","article-title":"Fetal vasculogenesis and angiogenesis in human placental villi","volume":"136","author":"Demir","year":"1989","journal-title":"Acta Anat (Basel)"},{"key":"10.1002\/jps.22642_bb0070","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0002-9378(97)70572-6","article-title":"Maternal circulation in the first-trimester human placenta\u2014Myth or reality","volume":"176","author":"Jaffe","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/jps.22642_bb0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/1071-5576(96)00023-8","article-title":"Effect of physiologic perfusion\u2013fixation on the morphometrically evaluated dimensions of the term placental cotyledon","volume":"3","author":"Luckhardt","year":"1996","journal-title":"J Soc Gynecol Investig"},{"key":"10.1002\/jps.22642_bb0080","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1471-0528.1986.tb07830.x","article-title":"Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants","volume":"93","author":"Khong","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1002\/jps.22642_bb0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00160054","article-title":"Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta","volume":"26","author":"MacFarland","year":"1994","journal-title":"Histochem J"},{"key":"10.1002\/jps.22642_bb0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.placenta.2010.02.010","article-title":"Placental P-glycoprotein and breast cancer resistance protein: Influence of polymorphisms on fetal drug exposure and physiology","volume":"31","author":"Hutson","year":"2010","journal-title":"Placenta"},{"key":"10.1002\/jps.22642_bb0095","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1124\/dmd.104.003335","article-title":"Variable expression of MRP2 (ABCC2) in human placenta: Influence of gestational age and cellular differentiation","volume":"33","author":"Meyer zu Schwabedissen","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.22642_bb0100","doi-asserted-by":"crossref","first-page":"R1495","DOI":"10.1152\/ajpregu.2000.279.4.R1495","volume":"279","author":"St-Pierre","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1002\/jps.22642_bb0105","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res"},{"key":"10.1002\/jps.22642_bb0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1002\/jps.22642_bb0115","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.placenta.2005.05.007","article-title":"Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation","volume":"27","author":"Sun","year":"2006","journal-title":"Placenta"},{"key":"10.1002\/jps.22642_bb0120","doi-asserted-by":"crossref","first-page":"E1295","DOI":"10.1152\/ajpendo.00193.2006","article-title":"Expression of the breast cancer resistance protein (Bcrp1\/Abcg2) in tissues from pregnant mice: Effects of pregnancy and correlations with nuclear receptors","volume":"291","author":"Wang","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1002\/jps.22642_bb0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.placenta.2004.05.013","article-title":"P-Glycoprotein expression of the human placenta during pregnancy","volume":"26","author":"Gil","year":"2005","journal-title":"Placenta"},{"key":"10.1002\/jps.22642_bb0130","doi-asserted-by":"crossref","first-page":"R963","DOI":"10.1152\/ajpregu.00173.2005","article-title":"P-Glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages","volume":"289","author":"Mathias","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1002\/jps.22642_bb0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1124\/dmd.107.017699","article-title":"Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein","volume":"36","author":"Morimoto","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.22642_bb0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/dmd.107.018556","article-title":"P-Glycoprotein restricts the penetration of oseltamivir across the blood\u2013brain barrier","volume":"36","author":"Ose","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.22642_bb0145","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00002030-200103090-00007","article-title":"Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood\u2013brain barrier","volume":"15","author":"Van Der Sandt","year":"2001","journal-title":"AIDS"},{"key":"10.1002\/jps.22642_bb0150","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00002030-200107270-00004","article-title":"P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: Potential for accelerated viral drug resistance","volume":"15","author":"Jones","year":"2001","journal-title":"AIDS"},{"key":"10.1002\/jps.22642_bb0155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2007.02.036","article-title":"Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor","volume":"339","author":"Agarwal","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22642_bb0160","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/jnr.21898","article-title":"Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line","volume":"87","author":"Zastre","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1002\/jps.22642_bb0165","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1124\/dmd.107.017723","article-title":"P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution","volume":"35","author":"Shaik","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.22642_bb0170","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.00671-07","article-title":"Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro","volume":"51","author":"Tong","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.22642_bb0175","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1248\/bpb.32.1588","article-title":"P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines","volume":"32","author":"Fujimoto","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.22642_bb0180","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0143-4004(03)00170-X","article-title":"Basal membrane localization of MRP1 in human placental trophoblast","volume":"24","author":"Nagashige","year":"2003","journal-title":"Placenta"},{"key":"10.1002\/jps.22642_bb0185","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/00002030-200211220-00009","article-title":"Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs","volume":"16","author":"Huisman","year":"2002","journal-title":"AIDS"},{"key":"10.1002\/jps.22642_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9440(10)62230-4","article-title":"Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: Effects of gestational age and cellular differentiation","volume":"166","author":"Meyer","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1002\/jps.22642_bb0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/jop.2008.0084","article-title":"Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux","volume":"25","author":"Karla","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1002\/jps.22642_bb0200","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1124\/dmd.106.014274","article-title":"Abcg2\/Bcrp1 mediates the polarized transport of antiretroviral nucleosides abacavir and zidovudine","volume":"35","author":"Pan","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.22642_bb0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2007.02944.x","article-title":"The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine","volume":"64","author":"Kim","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/jps.22642_bb0210","doi-asserted-by":"crossref","first-page":"R1809","DOI":"10.1152\/ajpregu.00293.2007","article-title":"In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta","volume":"293","author":"Govindarajan","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1002\/jps.22642_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09687680110048318","article-title":"Transport of antiviral 3\u2032-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes","volume":"18","author":"Yao","year":"2001","journal-title":"Mol Membr Biol"},{"key":"10.1002\/jps.22642_bb0220","doi-asserted-by":"crossref","first-page":"E390","DOI":"10.1152\/ajpendo.00257.2002","article-title":"Characterization and identification of steroid sulfate transporters of human placenta","volume":"284","author":"Ugele","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1002\/jps.22642_bb0225","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/jpet.300.3.918","article-title":"Human organic anion transporters and human organic cation transporters mediate renal antiviral transport","volume":"300","author":"Takeda","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.22642_bb0230","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/jpet.105.086827","article-title":"Functional analysis of organic cation transporter 3 expressed in human placenta","volume":"315","author":"Sata","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.22642_bb0235","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/jpet.108.146225","article-title":"Transport of lamivudine [(-)-beta-L-2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3","volume":"329","author":"Minuesa","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.22642_bb0240","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1933719107303856","article-title":"Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone","volume":"14","author":"Petropoulos","year":"2007","journal-title":"Reprod Sci"},{"key":"10.1002\/jps.22642_bb0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/geno.1998.5639","article-title":"Cloning of the mouse and human solute carrier 22a3 (Slc22a3\/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27","volume":"55","author":"Verhaagh","year":"1999","journal-title":"Genomics"},{"key":"10.1002\/jps.22642_bb0250","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1210\/jcem.87.4.8431","article-title":"Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta","volume":"87","author":"St-Pierre","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/jps.22642_bb0255","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family: Biopharmaceutical, physiological, and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22642_bb0260","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/MCB.21.13.4188-4196.2001","article-title":"Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3\/Slc22a3-deficient mice","volume":"21","author":"Zwart","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1002\/jps.22642_bb0265","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2174\/138920009789375360","article-title":"Organic cation transporters: Physiology, toxicology and special focus on ethidium as a novel substrate","volume":"10","author":"Lee","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1002\/jps.22642_bb0270","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1387\/ijdb.082765md","article-title":"Placental nutrient supply and fetal growth","volume":"54","author":"Desforges","year":"2010","journal-title":"Int J Dev Biol"},{"key":"10.1002\/jps.22642_bb0275","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/jama.2010.479","article-title":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States","volume":"303","author":"Siston","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/jps.22642_bb0280","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1471-0528.2000.tb11621.x","article-title":"Influenza virus infection in the second and third trimesters of pregnancy: A clinical and seroepidemiological study","volume":"107","author":"Irving","year":"2000","journal-title":"BJOG"},{"key":"10.1002\/jps.22642_bb0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1503\/cmaj.090866","article-title":"Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women","volume":"181","author":"Tanaka","year":"2009","journal-title":"CMAJ"},{"key":"10.1002\/jps.22642_bb0290","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/AOG.0b013e3181d44752","article-title":"Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications","volume":"115","author":"Greer","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1002\/jps.22642_bb0295","doi-asserted-by":"crossref","first-page":"927574","DOI":"10.1155\/2008\/927574","article-title":"The metabolism and transplacental transfer of oseltamivir in the ex vivo human model","volume":"2008","author":"Worley","year":"2008","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1002\/jps.22642_bb0300","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI7963","article-title":"Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure","volume":"104","author":"Smit","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1002\/jps.22642_bb0305","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0960327108088971","article-title":"Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta","volume":"27","author":"Rahi","year":"2008","journal-title":"Hum Exp Toxicol"},{"key":"10.1002\/jps.22642_bb0310","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00008571-200405000-00006","article-title":"Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1)","volume":"14","author":"Hitzl","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1002\/jps.22642_bb0315","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0022-3565(24)29643-9","article-title":"Expression of P-glycoprotein in human placenta: Relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene","volume":"297","author":"Tanabe","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.22642_bb0320","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/dmd.108.024018","volume":"37","author":"Ose","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.22642_bb0325","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.earlhumdev.2005.02.002","article-title":"Transfer of antivirals across the human placenta","volume":"81","author":"Pacifici","year":"2005","journal-title":"Early Hum Dev"},{"key":"10.1002\/jps.22642_bb0330","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/jac\/dkm411","article-title":"HIV and mitochondrial toxicity in children","volume":"61","author":"Foster","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.22642_bb0335","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1128\/AAC.48.11.4332-4336.2004","article-title":"Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women","volume":"48","author":"Chappuy","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.22642_bb0340","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0028-2243(91)90122-2","article-title":"Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy: Study by direct fetal blood sampling under ultrasound","volume":"40","author":"Pons","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1002\/jps.22642_bb0345","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(89)90449-2","article-title":"Fetoplacental passage of zidovudine","volume":"2","author":"Gillet","year":"1989","journal-title":"Lancet"},{"key":"10.1002\/jps.22642_bb0350","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0002-9378(11)90791-1","volume":"168","author":"O'Sullivan","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/jps.22642_bb0355","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000441-199001000-00005","article-title":"Azidothymidine (zidovudine) transport by the human placenta","volume":"299","author":"Schenker","year":"1990","journal-title":"Am J Med Sci"},{"key":"10.1002\/jps.22642_bb0360","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/infdis\/161.2.203","article-title":"Transfer of zidovudine (AZT) by human placenta","volume":"161","author":"Liebes","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1002\/jps.22642_bb0365","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1113\/jphysiol.2008.156133","article-title":"Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in mice","volume":"586","author":"Coan","year":"2008","journal-title":"J Physiol"},{"key":"10.1002\/jps.22642_bb0370","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2004.11.005","article-title":"Cell entry and export of nucleoside analogues","volume":"107","author":"Pastor-Anglada","year":"2005","journal-title":"Virus Res"},{"key":"10.1002\/jps.22642_bb0375","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s11095-008-9564-9","article-title":"Characterization of the mechanism of zidovudine uptake by rat conditionally immortalized syncytiotrophoblast cell line TR-TBT","volume":"25","author":"Sai","year":"2008","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22642_bb0380","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1124\/dmd.108.021345","article-title":"Enhancement of zidovudine uptake by dehydroepiandrosterone sulfate in rat syncytiotrophoblast cell line TR-TBT 18d-1","volume":"36","author":"Nishimura","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.22642_bb0385","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1067\/mob.2001.108344","article-title":"Maternal\u2013fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women","volume":"184","author":"Mandelbrot","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/jps.22642_bb0390","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0140-6736(91)90313-E","article-title":"Fetoplacental passage of 2\u2032,3\u2032-dideoxyinosine","volume":"337","author":"Pons","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/jps.22642_bb0395","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1096\/fasebj.9.12.7672508","article-title":"Developmental pharmacology and toxicology of anti-HIV therapeutic agents: Dideoxynucleosides","volume":"9","author":"Sandberg","year":"1995","journal-title":"FASEB J"},{"key":"10.1002\/jps.22642_bb0400","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.placenta.2008.11.022","article-title":"Influx mechanism of 2\u2032,3\u2032-dideoxyinosine and uridine at the blood\u2013placenta barrier","volume":"30","author":"Sato","year":"2009","journal-title":"Placenta"},{"key":"10.1002\/jps.22642_bb0405","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.placenta.2008.01.010","article-title":"Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1","volume":"29","author":"Chishu","year":"2008","journal-title":"Placenta"},{"key":"10.1002\/jps.22642_bb0410","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/dmd.105.006270","article-title":"Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2","volume":"34","author":"Owen","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.22642_bb0415","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ajog.2004.01.034","article-title":"Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus","volume":"191","author":"Chappuy","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/jps.22642_bb0420","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00002030-200204120-00008","article-title":"Transplacental passage of protease inhibitors at delivery","volume":"16","author":"Marzolini","year":"2002","journal-title":"AIDS"},{"key":"10.1002\/jps.22642_bb0425","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clpt.2005.04.014","article-title":"Functional role of P-glycoprotein in the human blood-placental barrier","volume":"78","author":"Molsa","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.22642_bb0430","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2125.2007.03067.x","article-title":"Inhibition of placental P-glycoprotein: Impact on indinavir transfer to the foetus","volume":"65","author":"Sudhakaran","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/jps.22642_bb0435","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1743-422X-6-40","article-title":"Herpes simplex virus infection in pregnancy and in neonate: Status of art of epidemiology, diagnosis, therapy and prevention","volume":"6","author":"Anzivino","year":"2009","journal-title":"Virol J"},{"key":"10.1002\/jps.22642_bb0440","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/bdra.20013","article-title":"Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984\u20131999","volume":"70","author":"Stone","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1002\/jps.22642_bb0445","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1124\/jpet.103.057109","article-title":"Transport of amino acid-based prodrugs by the Na+- and Cl(-) -coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery","volume":"308","author":"Hatanaka","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.22642_bb0450","doi-asserted-by":"crossref","first-page":"23740","DOI":"10.1074\/jbc.274.34.23740","article-title":"Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+)","volume":"274","author":"Sloan","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.22642_bb0455","doi-asserted-by":"crossref","first-page":"12118","DOI":"10.1016\/S0021-9258(17)38994-9","article-title":"Na+-dependent transport of basic, zwitterionic, and bicyclic amino acids by a broad-scope system in mouse blastocysts","volume":"260","author":"Van Winkle","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.22642_bb0460","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/humupd\/dmi044","article-title":"System B0,+ amino acid transport regulates the penetration stage of blastocyst implantation with possible long-term developmental consequences through adulthood","volume":"12","author":"Van Winkle","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1002\/jps.22642_bb0465","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/bbrc.1998.9298","article-title":"Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir","volume":"250","author":"Balimane","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/jps.22642_bb0470","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/bbrc.1998.8628","article-title":"Valacyclovir: A substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2","volume":"246","author":"Ganapathy","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/jps.22642_bb0475","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/dmd.31.2.153","article-title":"The presence of xenobiotic transporters in rat placenta","volume":"31","author":"Leazer","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.22642_bb0480","first-page":"311","article-title":"Successful management of varicella pneumonia complicating pregnancy. A report of three cases","volume":"31","author":"Landsberger","year":"1986","journal-title":"J Reprod Med"},{"key":"10.1002\/jps.22642_bb0485","first-page":"885","article-title":"Acyclovir transport by the human placenta","volume":"120","author":"Henderson","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1002\/jps.22642_bb0490","first-page":"23","article-title":"Prevention of maternal cytomegalovirus infection: Current status and future prospects","volume":"2","author":"Nyholm","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.1002\/jps.22642_bb0495","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J Pediatr"},{"key":"10.1002\/jps.22642_bb0500","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-199039040-00008","article-title":"Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections","volume":"39","author":"Faulds","year":"1990","journal-title":"Drugs"},{"key":"10.1002\/jps.22642_bb0505","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/00006454-200208000-00023","article-title":"Placental transfer of ganciclovir in a woman with acquired immunodeficiency syndrome and cytomegalovirus disease","volume":"21","author":"Brandy","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/jps.22642_bb0510","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1023\/B:PHAM.0000033019.49737.28","article-title":"Transport of amino acid esters and the amino-acid-based prodrug valganciclovir by the amino acid transporter ATB(0,+)","volume":"21","author":"Umapathy","year":"2004","journal-title":"Pharm Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915319778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915319778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T22:05:17Z","timestamp":1741212317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915319778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0022354915319778"],"URL":"https:\/\/doi.org\/10.1002\/jps.22642","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}